Sapphire Medical Clinics
Our aim is to enable access to medicinal cannabis for patients who will derive clinical benefit through consultation with expert doctors working within a framework approved by all relevant medical regulatory authorities.
Formed by doctors for the mutual benefit of patients and doctors
Our aim is to enable access to medicinal cannabis for patients who will derive clinical benefit through consultation with expert doctors working within a framework approved by all relevant regulatory authorities.
Sapphire Medical Clinics were formed by doctors for doctors. We aim to become a trusted partner of NHS medical professionals and support patients in using medicinal cannabis where appropriate.
Sapphire Clinics Multidisciplinary Team
Dr Michael Platt MA MBBS FRCA FFPMRCA
Dr Platt has been a consultant and honorary senior lecturer in pain medicine and anaesthetics at Imperial College since 1991.
Following medical training in Australia, he undertook specialist training in anaesthetics and pain medicine in London. He is a professional and highly effective senior consultant in pain medicine and anaesthetics with over 23 years in senior clinical leadership and specialist roles. In his NHS practice he is a senior consultant at the Imperial Pain Clinic and is frequently referred complex patients from other specialists in the UK and abroad.
Professor Praveen Anand
MD, MA, FRCP
Neurology / Neuropathic Pain
Professor Praveen Anand is Professor of Clinical Neurology and honorary Consultant Neurologist at Imperial College London.
Dr Mark Weatherall
MBBC, FRCP, PhD, MA
Dr Mark Weatherall is a Consultant Neurologist at Stoke Mandeville Hospital in the Buckinghamshire Healthcare NHS Trust.
Dr Shaheen Khan
BSc, MSc, MBBS, FRCP
Dr Shaheen Khan is a consultant in palliative medicine and lead clinician for the Guy’s and St Thomas’ NHS Foundation Trust.
Dr Jonathan Hoare
MA, FRCP, PhD
Gastroenterology / General Medicine
Dr Hoare is a consultant gastroenterologist and head of endoscopy for the Imperial College hospitals.
Dr James Rucker
MBBS, BSc, MRCPsych, PhD
Dr Rucker is a Clinician Scientist (senior clinical lecturer level) at The Institute of Psychiatry, Psychology and Neuroscience at King’s College London.
Dr Sushil Beri
MBBS, MD, DNB, MRCPCH
Dr Beri is a consultant paediatric neurologist at Imperial College Healthcare NHS Trust.
Managing Director and Academic Lead for Sapphire Medical Clinics, Dr Mikael Sodergren, explains why we set up Sapphire Medical Clinics
He explores the uses of medical cannabis, describing its applications and discusses the future of cannabinoid research in the short and long-term.
On the 29th October 2019, we held our first medical education event at the RSM (Royal Society of Medicine). We received over 400 registrations and were joined on the night by GPs, Hospital Consultants and interested parties.
- Dr Zeid Mohamedali MD, PhD, FRCSC: Chief Medical Officer, Zenabis Global and Adult and Paediatric Urology, British Columbia
- Dr Peter Irving MA MD MRCP: Consultant Gastroenterologist, Guys and St Thomas Hospital London
- Dr Amir Englund: PhD Cannabinoid Psychopharmacology, Institute of Psychiatry, King’s College London
- Professor Praveen Anand MD., M.R.C.P., F.R.C.P: Professor of Neurology, Imperial College London
“Excellent event with interesting speakers in a fantastic location.”
“Great event, look forward to more from Sapphire and their team. Thank you.”
“Thanks for the educational evening.”
Excellent event with interesting speakers in a fantastic location.
Great event, look forward to more from Sapphire and their team. Thank you.
Thanks for the educational evening.
Our patients have a ‘Patients Know Best’ account created for them once they have been referred to our clinic.
This gives them access to all of their medical information for their medicinal cannabis treatment. It also allows them to use our uniquely designed symptom checker to report any change in condition since starting treatment with medicinal cannabis and allows us to keep track of doses.
Follow-up procedures will ensure a high level of pharmacovigilance and surveillance with immediate reporting of adverse events to a national database.
Structure Of The Clinic
What legal changes have been made?
On 1st November 2018 the law in the UK was changed regarding medicinal cannabis. The change was to the Misuse of Drugs regulations 2001. Medical cannabis was re-scheduled from a schedule 1 drug (this means of no medical benefit) to a schedule 2 drug (this allows doctors to prescribe medicinal cannabis in certain situations).
In practice this means that some patients who have exhausted conventional therapies are able to receive a prescription for medicinal cannabis. Only doctors on the specialist register of the GMC are authorised to prescribe cannabis medications, and satisfy the the guidelines issued by GMC, NHS England and MHRA.
Sapphire Medical Clinics is the first UK medical cannabis clinic registered by the CQC
RECEIVE EMAIL UPDATES
Sign up to hear news from Sapphire including our clinic openings and industry updates relating to access to medical cannabis